Short intensive primary chemotherapy and radiotherapy in Sporadic primary CNS lymphoma (PCL)

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 5, 1998, Pages 1157-1162

  Brada, Michael ^a   Hjiyiannakis, Dennis ^a   Hines, Frances ^a   Traish, Daphne ^a   Ashley, Susan ^b  

^a The Roy Marsden NHS T   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Chemotherapy; Primary CNS lymphoma; Radiotherapy

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; NYSTATIN; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; LEUCOVORIN; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; VINCRISTINE;

EID: 0032521494     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00002-9     Document Type: Article

References (17)

1. Brada M., Dearnaley D., Horwich A., Bloom H. J. G. Management of primary cerebral lymphoma with initial chemotherapy Preliminary results and comparison with patients treated with radiotherapy alone . Int. J. Radiat. Oncol. Biol. Phys. 18:1990;787-792.
2. Nelson D. F., Martz K. L., Bonner H., Nelson J. S., Newall J., Kerman H. D., Thomas J. W., Murray K. J. Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;9-17.
3. Brada M. Central nervous system lymphomas Progress in chemotherapy and radiotherapy [editorial; comment] . Int. J. Radiat. Oncol. Biol. Phys. 33:1995;769-771.
4. O'Neill B. P., O'Fallon J. R., Earle J. D., Colgan J. P., Brown L. D., Krigel R. L. Primary central nervous system non-Hodgkin's lymphoma Survival advantages with combined initial therapy? Int. J. Radiat. Oncol. Biol. Phys. 33:1995;663-673.
5. Schultz C., Scott C., Sherman W., Donahue B., Fields J., Murray K., Fisher B., Abrams R., Meis-Kindblom J. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas Initial report of Radiation Therapy Oncology Group Protocol 88-06 . J. Clin. Oncol. 14:1996;556-564.
6. Neuwelt E. A., Goldman D. L., Dahlborg S. A., Crossen J., Ramsey F., Roman-Goldstein S., Braziel R., Dana B. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption Prolonged survival and preservation of cognitive function . J. Clin. Oncol. 9:1991;1580-1590.
7. De Angelis L. M., Yahalom J., Heinemann M. H., Cirrincione C., Thaler H. T., Krol G. Primary CNS lymphoma Combined treatment with chemotherapy and radiotherapy . Neurology. 40:1990;80-86.
8. Gabbai A., Hochberg F., Linggood R., Bashir R., Hottleman K. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J. Neurosurg. 70:1989;190-194.
9. Bessell E. M., Graus F., Punt J. A. G., Firth J. L., Hope D. T., Moloney A. J., Lopez-Guillermo A., Villa S. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J. Clin. Oncol. 14:1996;945-954.
10. Klimo P., Connors J. M. MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann. Intern. Med. 102:1985;596-602.
11. Ott R. J., Brada M., Flower M. A., Babich J. W., Cherry S., Deehan B. Measurements of blood-brain barrier permeability in patients undergoing radio-chemotherapy for primary cerebral tumours. Eur. J. Cancer. 27:1991;1356-1361.
12. Prognostic factors for high-grade malignant glioma Development of a prognostic index . J. Neurooncol. 9:1990;47-55.
13. Kaplan E. L., Meier P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-458.
14. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Cancer. 49:1982;2112-2135.
15. Eby M., Grufferman S., Flannelly C. M. Increasing incidence of primary brain lymphoma in the US. Cancer. 62:1988;2461-2462.
16. Fisher R. I., Gaynor E. R., Dahlberg S., Oken M. M., Grogan T. M., Mize E. M., Glick J. H., Coltman C. A. J., Miller T. P. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med. 328:1993;1002-1006.
17. De Angelis L. M., Yahalom J., Thaler H. T., Kher U. Combined modality therapy for primary CNS lymphoma. J. Clin. Oncol. 10:1992;635-643.